Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MOTSNASDAQ:NMRDNASDAQ:UTRSNASDAQ:VIVE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMOTSMotus GI$0.00$0.00$0.00▼$0.19$2K0.284,720 shs6,601 shsNMRDNemaura Medical$0.00$0.00$0.00▼$0.06$4K0.638,864 shs1,201 shsUTRSMinerva Surgical$0.00$0.00▼$0.00$1K3.921,325 shsN/AVIVEViveve Medical$0.00$0.00$0.00▼$0.02$1K0.33,057 shs136 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMOTSMotus GI0.00%0.00%+200.00%+200.00%-99.63%NMRDNemaura Medical0.00%0.00%-50.00%0.00%-99.80%UTRSMinerva Surgical0.00%0.00%0.00%0.00%-90.00%VIVEViveve Medical0.00%0.00%-50.00%-50.00%-66.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMOTSMotus GIN/AN/AN/AN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/AN/AN/AN/AUTRSMinerva SurgicalN/AN/AN/AN/AN/AN/AN/AN/AVIVEViveve MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMOTSMotus GI 0.00N/AN/AN/ANMRDNemaura Medical 0.00N/AN/AN/AUTRSMinerva Surgical 0.00N/AN/AN/AVIVEViveve Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMOTSMotus GI$319K0.01N/AN/A$1.74 per share0.00NMRDNemaura Medical$3.02K1.34N/AN/A($0.41) per share0.00UTRSMinerva Surgical$51.69M0.00N/AN/AN/ANaNVIVEViveve Medical$6.83M0.00N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMOTSMotus GI-$12.87M-$15.64N/A∞N/AN/AN/AN/AN/ANMRDNemaura Medical-$14.14M-$0.39N/A∞N/AN/AN/AN/AN/AUTRSMinerva Surgical-$34.11MN/A0.00N/AN/AN/AN/AN/AN/AVIVEViveve MedicalN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMOTSMotus GIN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/AUTRSMinerva SurgicalN/AN/AN/AN/AN/AVIVEViveve MedicalN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMOTSMotus GI20.06%NMRDNemaura Medical4.41%UTRSMinerva SurgicalN/AVIVEViveve MedicalN/AInsider OwnershipCompanyInsider OwnershipMOTSMotus GI0.34%NMRDNemaura Medical40.42%UTRSMinerva Surgical8.50%VIVEViveve Medical5.73%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMOTSMotus GI305.77 million5.75 millionNot OptionableNMRDNemaura Medical4040.35 million24.04 millionNo DataUTRSMinerva Surgical1608.88 million8.12 millionNot OptionableVIVEViveve Medical7010.67 millionN/ANot OptionableVIVE, NMRD, MOTS, and UTRS HeadlinesRecent News About These CompaniesSharing medical andOctober 25, 2024 | news-medical.netViveve Medical Inc (VIVE)July 24, 2024 | investing.comIncontinence Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key CompaniesJuly 19, 2024 | finance.yahoo.comVaginal Rejuvenation Is Big BusinessJuly 19, 2024 | ca.style.yahoo.com5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028April 17, 2024 | finance.yahoo.comInMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTLApril 15, 2024 | finance.yahoo.comViveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, PredictionsFebruary 23, 2024 | benzinga.comThe Best Medical Billing Services of 2024January 19, 2024 | business.comVIVE Viveve Medical, Inc.July 29, 2023 | seekingalpha.comInMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve PatentsJuly 25, 2023 | finance.yahoo.comVIVE - Viveve Medical, Inc.June 14, 2023 | uk.finance.yahoo.comViveve Medical, Inc. (VIVE)February 24, 2023 | finance.yahoo.comViveve Medical announces study result from PURSUIT clinical trial to treat female stress urinary incontinenceJanuary 20, 2023 | pharmabiz.comWhy Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 17, 2023 | msn.comViveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceJanuary 17, 2023 | finanznachrichten.deViveve crashes ~60% as company decides to delist, explore sale after trial failsJanuary 17, 2023 | seekingalpha.comViveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceJanuary 17, 2023 | finance.yahoo.comViveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence TrialJanuary 17, 2023 | finance.yahoo.comWhy Is Viveve Medical (VIVE) Stock Down 69% Today?January 17, 2023 | investorplace.comViveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call TranscriptDecember 29, 2022 | insidermonkey.comNew MarketBeat Followers Over TimeVIVE, NMRD, MOTS, and UTRS Company DescriptionsMotus GI NASDAQ:MOTS$0.0003 0.00 (0.00%) As of 05/23/2025 03:37 PM EasternMotus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.Nemaura Medical NASDAQ:NMRD$0.0001 0.00 (0.00%) As of 05/22/2025 09:30 AM EasternNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.Minerva Surgical NASDAQ:UTRSMinerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.Viveve Medical NASDAQ:VIVE$0.0001 0.00 (0.00%) As of 05/23/2025 10:30 AM EasternViveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
